Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.78 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.78 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.56 |
| ▸ | NPC1 | O15118 | 1/20 | 0.52 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.52 |
| ▸ | RAB9A | P51151 | 1/20 | 0.52 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.52 |
| ▸ | RELA | Q04206 | 1/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.52 |
| ▸ | MAPK13 | O15264 | 3/20 | 0.48 |
| ▸ | GCGR | P47871 | 3/20 | 0.48 |
| ▸ | MAPK12 | P53778 | 3/20 | 0.48 |
| ▸ | MAPK11 | Q15759 | 3/20 | 0.48 |
| ▸ | MAPK14 | Q16539 | 3/20 | 0.48 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.48 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10019513 | 1.00 | ALDH1A1 (0.78) | ALDH1A1MAPK1TDP1NPC1NFKB1 | |
| SCHEMBL5804045 | 1.00 | ALDH1A1 (0.78) | ALDH1A1MAPK1TDP1NPC1NFKB1 | |
| SCHEMBL13777185 | 0.90 | MAPK1 (0.64) | ALDH1A1MAPK1TDP1NPC1NFKB1 | |
| SCHEMBL13777184 | 0.90 | MAPK1 (0.64) | ALDH1A1MAPK1TDP1NPC1NFKB1 | |
| SCHEMBL22143498 | 0.88 | ALDH1A1 (0.61) | ALDH1A1MAPK1TDP1NPC1NFKB1 | |
| SCHEMBL22143642 | 0.88 | ALDH1A1 (0.61) | ALDH1A1MAPK1TDP1NPC1NFKB1 | |
| SCHEMBL22143646 | 0.88 | ALDH1A1 (0.61) | ALDH1A1MAPK1TDP1NPC1NFKB1 | |
| SCHEMBL22143503 | 0.88 | ALDH1A1 (0.61) | ALDH1A1MAPK1TDP1NPC1NFKB1 | |
| SCHEMBL20160809 | 0.88 | ALDH1A1 (0.61) | ALDH1A1MAPK1TDP1NPC1NFKB1 | |
| SCHEMBL22143499 | 0.88 | ALDH1A1 (0.61) | ALDH1A1MAPK1TDP1NPC1NFKB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150126773-A1 | USE OF SOLUTIONS OF SYNTHETIC ALKYLATED GRAPHENES SOLUTIONS FOR MULTIPHASE FLOW TEST FLUIDS TO BE USED BY THE OIL AND GAS INDUSTRY | SINVENT AS (NO) | 2015-05-07 | — | — | US | disclosed |
| US-20150126773-A1 | USE OF SOLUTIONS OF SYNTHETIC ALKYLATED GRAPHENES SOLUTIONS FOR MULTIPHASE FLOW TEST FLUIDS TO BE USED BY THE OIL AND GAS INDUSTRY | SINVENT AS (NO) | 2015-05-07 | — | — | US | disclosed |
| US-20150126773-A1 | USE OF SOLUTIONS OF SYNTHETIC ALKYLATED GRAPHENES SOLUTIONS FOR MULTIPHASE FLOW TEST FLUIDS TO BE USED BY THE OIL AND GAS INDUSTRY | SINVENT AS (NO) | 2015-05-07 | — | — | US | disclosed |
| EP-1123337-B1 | CONJUGATED POLYMERS CONTAINING 2,7 FLUORENYL UNITS WITH IMPROVED PROPERTIES | MERCK PATENT GMBH (DE) | 2007-09-26 | — | — | EP | disclosed |
| US-6541602-B1 | Electroluminescent device containing a polyfluorene aromatic monomer, coupling through ring to a mono or polycyclic aromatic conjugated monomer having 5-20 carbon atoms | CELANESE VENTURES GMBH (DE) | 2003-04-01 | — | — | US | disclosed |
| EP-1123337-A1 | CONJUGATED POLYMERS CONTAINING 2,7 FLUORENYL UNITS WITH IMPROVED PROPERTIES | Celanese Ventures GmbH (DE) | 2001-08-16 | — | — | EP | disclosed |
| WO-2000022027-A1 | CONJUGATED POLYMERS CONTAINING 2,7 FLUORENYL UNITS WITH IMPROVED PROPERTIES | CELANESE VENTURES GMBH (DE) | 2000-04-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150126773-A1 | USE OF SOLUTIONS OF SYNTHETIC ALKYLATED GRAPHENES SOLUTIONS FOR MULTIPHASE FLOW TEST FLUIDS TO BE USED BY THE OIL AND GAS INDUSTRY | AGPAT2, LCAT, ARNT | ALDH1A1 2527/4885MAPK1 2784/4885TDP1 2774/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.